Vintrosa, Sweden

Mikael Andersson

This inventor holds 1 USPTO granted patent. Top assignee: Integrated Research Laboratories Sweden Ab. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mikael Andersson. Retrieved from https://idiyas.com/inventor/mikael-andersson-0zbtmomy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Mikael Andersson

Introduction

Mikael Andersson is a notable inventor based in Vintrosa, Sweden. He has made significant contributions to the field of neuroscience through his innovative work on dopamine neurotransmission. His research focuses on developing novel compounds that can stabilize dopaminergic activity, which is crucial for various therapeutic applications.

Latest Patents

Mikael holds a patent for his invention titled "Modulators of dopamine neurotransmission." This patent involves novel 1-(4H-1,3-benzodioxin-2-yl)methanamine derivatives that serve as modulators of dopamine neurotransmission. The invention is particularly relevant for its potential use in therapeutic methods and pharmaceutical compositions that incorporate these compounds.

Career Highlights

Mikael is currently associated with Integrated Research Laboratories Sweden AB, where he continues to advance his research in the field. His work has garnered attention for its potential impact on treating neurological disorders related to dopamine dysregulation.

Collaborations

Mikael collaborates with esteemed colleagues such as Clas Sonesson and Peder Svensson. Their combined expertise enhances the research and development efforts at Integrated Research Laboratories Sweden AB.

Conclusion

Mikael Andersson's innovative contributions to dopamine neurotransmission research highlight his role as a significant inventor in the field. His patent and ongoing work promise to advance therapeutic options for neurological conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…